You take your folic acid every day during pregnancy. You eat well. Yet something still goes wrong — the baby arrives too early. For many women who experience preterm birth, there is no clear explanation. Emerging research now points to a largely overlooked biological mechanism: folate receptor autoantibodies (FRAbs) — immune proteins that block the receptor responsible for transporting folate to your baby. Understanding the role of folate receptor autoantibodies in preterm birth may offer answers — and hope — for women dealing with premature delivery or recurrent pregnancy complications.
In this article, we explain what FRAbs are, how they disrupt pregnancy, the research behind this connection, and what can be done if you test positive — including why standard prenatal nutritional support alone is not always enough.
What Is Folate and Why Does It Matter in Pregnancy?
Folate, also known as Vitamin B9, is one of the most essential nutrients during pregnancy. It drives DNA synthesis, supports cell division, and enables healthy neural tube formation in the embryo during the first weeks after conception — often before a woman even knows she is pregnant.
Most women are advised to take folic acid supplements from the time they plan to conceive. This advice has significantly reduced the incidence of neural tube defects worldwide. However, folic acid supplementation alone cannot protect against pregnancy complications when the body’s ability to transport folate to the fetus is actively being blocked.
That is precisely what folate receptor autoantibodies do.
Understanding Folate Receptors and How They Work
Folate cannot simply diffuse through cell membranes on its own. It needs a transporter — a specialised protein called the folate receptor alpha (FRα) — to be taken up by cells. FRα is present in high concentrations on the surface of the placenta and the choroid plexus (the structure that supplies folate to the brain and cerebrospinal fluid).
During pregnancy, the placenta expresses FRα specifically to capture folate from the mother’s bloodstream and deliver it to the growing fetus. Without this receptor functioning correctly, the fetus may not receive adequate folate — even when the mother has normal or even high blood folate levels.
What Are Folate Receptor Autoantibodies?
Autoantibodies are proteins that the immune system mistakenly produces against the body’s own tissues. In some individuals, the immune system generates antibodies directed against folate receptor alpha — these are called folate receptor autoantibodies (FRAbs).
Two types are identified:
- Blocking FRAbs: Attach to the folate receptor and physically prevent folate from binding. This stops folate from being transported across the placenta or into the brain.
- Binding FRAbs: Attach to a different part of the receptor and are associated with disrupted folate metabolism at the cellular level.
Both types can cross the placenta during pregnancy, meaning the fetus can also carry these autoantibodies in its own circulation — a finding that has significant implications for fetal development and infant health.
The Link Between Folate Receptor Autoantibodies and Preterm Birth
A key observational study published in the journal Nutrition (Vo et al., 2015) investigated the prevalence of FRAbs in 23 mothers of preterm infants compared with 25 mothers of full-term infants. The findings were striking:
- FRAbs were detected in 65.2% of mothers who had a preterm birth, compared with only 28% of mothers with term pregnancies — a more than twofold difference.
- Among the infants themselves, FRAbs were found in 64% of preterm babies versus 24% of term babies.
- After adjusting for maternal age and previous preterm birth, women with positive FRAbs had nearly five times the odds of experiencing preterm birth (OR 4.9; 95% CI 1.4–17.7).
This research, published on PubMed (PMID: 26238535), suggests FRAbs are not merely a coincidental finding — they appear to be an active contributor to premature delivery.
How Do FRAbs Lead to Preterm Birth?
The precise mechanism is still being studied, but several pathways have been proposed by researchers:
1. Impaired placental folate transport
FRα is expressed on trophoblast cells — the cells that form the placenta. When FRAbs bind to FRα on these cells, folate uptake by the placenta is disrupted. Reduced folate availability impairs DNA replication and cell division in the rapidly growing placenta and fetus.
2. Elevated homocysteine levels
Folate is essential for converting homocysteine into methionine. When folate delivery is blocked, homocysteine accumulates in the blood. High maternal homocysteine is a well-established risk factor for preterm birth, placental dysfunction, fetal growth restriction, and preeclampsia.
3. Immune-mediated inflammation at the maternal-fetal interface
FRAbs may trigger localised immune responses at the placental surface. FRα and FRβ are expressed on macrophages and decidual cells at the maternal-fetal interface — autoantibody binding at these sites can disrupt the immune balance required to maintain a healthy pregnancy.
4. Disrupted decidualisation and placental development
FRAbs may interfere with the normal transformation of the uterine lining. Impaired placentation has been linked to a smaller placental size and reduced blood flow between mother and fetus.
Beyond Preterm Birth: Broader Consequences of FRAbs
Research has linked folate receptor autoantibodies to a spectrum of pregnancy and developmental complications beyond preterm delivery:
Neural Tube Defects
FRAbs were first discovered in the context of neural tube defect (NTD) pregnancies. Women whose pregnancies were affected by NTDs showed significantly higher rates of these autoantibodies. Standard folic acid supplementation may not be sufficient to prevent NTDs in women who carry blocking FRAbs, since the supplemental folate cannot reach the fetus effectively.
Recurrent Miscarriage and Subfertility
FRAbs have been identified as a contributing factor in unexplained subfertility and recurrent pregnancy loss. In women with repeated miscarriages and no identifiable chromosomal or structural cause, testing for FRAbs can sometimes reveal an underlying autoimmune mechanism that had previously gone undetected.
Cerebral Folate Deficiency in Infants
When maternal FRAbs cross the placenta, the newborn may carry them too. In early infancy, these antibodies can block the folate receptor on the choroid plexus, preventing adequate folate from reaching the brain — a condition called cerebral folate deficiency (CFD). CFD can present as developmental regression, movement disorders, speech delay, and autistic features in young children.
Autism Spectrum Disorders
Research has found FRAbs in approximately 70% of children diagnosed with autism spectrum disorder (ASD). A randomised controlled trial found that high-dose folinic acid improved verbal communication in FRAb-positive children with ASD and language impairment.
Why Does the Immune System Produce These Autoantibodies?
One of the most important findings in this field concerns the role of dietary dairy. Research has shown that folate receptor proteins are present in cow’s milk and other animal milk. In genetically predisposed individuals, these milk-derived folate-binding proteins may trigger a gut immune response that produces antibodies cross-reactive with human FRα.
In simple terms: consuming dairy in susceptible individuals may lead the immune system to produce antibodies that inadvertently target the body’s own folate receptors. Other proposed mechanisms include gene mutations or epigenetic changes affecting the FRα protein structure.
Testing for Folate Receptor Autoantibodies
FRAbs are detected through a specialised blood test that measures both blocking and binding autoantibodies against FRα in serum. This test is typically performed after a period of regular dairy consumption (around two to three weeks) so that antibody levels are at their representative baseline.
Who should consider testing for folate receptor autoantibodies?
- Women with a history of preterm birth without a clearly identified cause
- Women with recurrent miscarriage or unexplained subfertility
- Women with a previous pregnancy affected by a neural tube defect
- Women planning pregnancy who have a personal or family history of autoimmune disorders
- Children showing signs of developmental delay, speech regression, or autistic features
At Altus Lab, Chandigarh, we offer a comprehensive range of specialised blood tests to support maternal and reproductive health. Our team can guide you on the right tests based on your history.
Treatment and Management Options
The good news is that FRAb-related pregnancy complications may be preventable and treatable with the right interventions. Current approaches used by clinicians include:
Folinic Acid (Leucovorin) Instead of Folic Acid
Standard folic acid must pass through the folate receptor to enter cells. Folinic acid (leucovorin or 5-formyltetrahydrofolate) can bypass blocked receptors by entering through an alternative pathway — the reduced folate carrier. For women with blocking FRAbs, folinic acid supplementation is therefore far more effective than standard folic acid.
A Dairy-Free Diet
Since animal milk proteins appear to be a key trigger for FRAb production in susceptible individuals, eliminating all animal-derived dairy products — including milk, cheese, yoghurt, butter, and milk-based infant formula — has been shown to reduce FRAb titres over time. Clinical studies have demonstrated that a milk-free diet, especially when combined with folinic acid supplementation, can bring autoantibody levels down to undetectable levels.
Immunomodulation
In severe cases with high FRAb titres and recurrent pregnancy loss, some specialists have used corticosteroids alongside folinic acid and a dairy-free diet to suppress the autoimmune response. This combination approach has been associated with successful term pregnancies in women who had previously experienced multiple losses.
An Important Note About Standard Folic Acid
It is critical to understand that routine folic acid supplementation alone does not protect against folate receptor autoantibody-related pregnancy complications. If the receptor through which folic acid enters cells is being blocked by autoantibodies, taking more folic acid will not solve the problem. This is why some women who faithfully take their prenatal vitamins still experience neural tube defects, preterm births, or miscarriages.
What This Means for Women in India
India has one of the highest burdens of preterm birth globally. While many factors contribute — including nutrition, infections, and access to antenatal care — the role of immune-mediated mechanisms like folate receptor autoantibodies remains underappreciated in clinical practice. For women in northern India, where dairy is a dietary staple and nutritional deficiencies are already common, the intersection of high dairy consumption, genetic predisposition, and nutrient gaps could make FRAb-related complications particularly relevant. Awareness and access to appropriate testing can potentially prevent cases of preterm delivery that currently go unexplained.
Key Takeaways
- Folate receptor autoantibodies (FRAbs) block the receptor responsible for transporting folate to the fetus, causing deficiency even with normal maternal folate levels.
- Women with FRAbs have nearly five times the odds of experiencing preterm birth compared to women without these antibodies.
- FRAbs can cross the placenta, affecting the newborn’s own folate transport and potentially contributing to cerebral folate deficiency or developmental disorders.
- Standard folic acid supplementation does not overcome the blockade — folinic acid (leucovorin) is a more effective alternative for affected women.
- A dairy-free diet has been shown to reduce FRAb levels and, combined with folinic acid, may help restore successful pregnancy outcomes.
- Testing for folate receptor autoantibodies should be considered in any woman with unexplained preterm birth, recurrent miscarriage, or a history of NTD pregnancies.
If you have experienced preterm birth, recurrent pregnancy loss, or are planning a pregnancy with risk factors, speaking to your doctor about folate receptor antibody testing is a meaningful step. Early detection opens the door to targeted intervention that standard prenatal supplementation alone cannot provide.
At Altus Lab, SCO 35, Sector 16-D, Chandigarh, we offer advanced pregnancy-related blood tests to support your maternal health journey. Call us at 0172-5017001 or contact us to learn more or to schedule a home sample collection at your convenience.
Reviewed by Dr. Alok Gupta, MD Pathology (Ex-PGIMER, Chandigarh).
This article is for informational purposes only and does not substitute personalised medical advice. Please consult your obstetrician or specialist for guidance specific to your health.
Frequently Asked Questions
Folate receptor autoantibodies (FRAbs) are immune proteins that the body produces against its own folate receptor alpha (FRα). They block or bind the receptor that normally transports folate across the placenta to the fetus, disrupting the baby’s folate supply even when the mother’s blood folate levels appear normal.
FRAbs cause preterm birth by blocking folate delivery to the placenta, elevating maternal homocysteine, triggering immune inflammation at the placental surface, and impairing placental development. Research shows women with FRAbs have nearly five times the risk of preterm birth.
No. Standard folic acid must pass through the folate receptor to enter cells. If that receptor is blocked by autoantibodies, additional folic acid cannot overcome the blockade. Folinic acid (leucovorin) is more effective because it enters cells through a different pathway and does not depend on the blocked receptor.
Research suggests that in susceptible individuals, folate-binding proteins in animal milk may trigger an immune response that produces antibodies cross-reactive with human FRα. Eliminating all animal-derived dairy has been shown to reduce FRAb levels, particularly when combined with folinic acid supplementation.
Testing is particularly relevant for women with a history of preterm birth without a clear cause, recurrent miscarriage, previous neural tube defect pregnancies, or unexplained subfertility. Children with developmental delays, speech regression, or features of autism may also benefit from FRAb testing.
Yes. Management typically involves switching from folic acid to folinic acid, adopting a strict dairy-free diet, and in severe cases, using low-dose corticosteroids under specialist supervision. This combined approach has helped women with recurrent FRAb-related pregnancy losses achieve successful full-term pregnancies.
